A new imaging technique using swept-source optical coherence tomography (OCT) shows promise for improving the diagnosis of ...

for endotracheal intubation or death within seven days for most patients with acute respiratory failure, according to a study published online Dec. 10 in the Journal of the American Medical ...

The researchers randomly assigned 1,766 hospitalized patients with acute respiratory failure (classified into five groups) to HFNO (883 patients) or NIV (883 patients). The researchers found that the ...

MONDAY, Dec. 16, 2024 (HealthDay News) — High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients with ...

High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients with acute respiratory failure, according to ...

The results of these two studies are in line with those of a network meta-analysis 9 that evaluated randomized clinical trials including patients with AHRF and compared the following treatments: ...

high-flow nasal oxygen met prespecified criteria for noninferiority for the primary outcome of endotracheal intubation or death within 7 days in 4 of the 5 patient groups with acute respiratory ...